Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Goodwill (2020 - 2025)

Pulmonx (LUNG) has disclosed Goodwill for 7 consecutive years, with $2.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Goodwill changed N/A to $2.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.3 million, a N/A change, with the full-year FY2024 number at $2.3 million, changed 0.0% from a year prior.
  • Goodwill was $2.3 million for Q3 2025 at Pulmonx, roughly flat from $2.3 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $2.3 million in Q2 2021 to a low of $2.3 million in Q1 2021.
  • A 5-year average of $2.3 million and a median of $2.3 million in 2021 define the central range for Goodwill.
  • Peak YoY movement for Goodwill: fell 1.41% in 2021, then rose 1.43% in 2022.
  • Pulmonx's Goodwill stood at $2.3 million in 2021, then rose by 1.43% to $2.3 million in 2022, then changed by 0.0% to $2.3 million in 2023, then changed by 0.0% to $2.3 million in 2024, then changed by 0.0% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Goodwill are $2.3 million (Q3 2025), $2.3 million (Q1 2025), and $2.3 million (Q4 2024).